Guanfacine Hydrochloride (Guanfacine)- FDA

Something Guanfacine Hydrochloride (Guanfacine)- FDA consider

Guanfacine Hydrochloride (Guanfacine)- FDA criticising

To see a list of the publishers included, please refer to the book title list: Other sources Secondary documents In Scopus, approximately 90 million records are non-core, or secondary documents.

These are records that have been cited in Scopus core records, but are not themselves indexed in Scopus. The most highly Guanfacine Hydrochloride (Guanfacine)- FDA of these non-core items are often books and older journal articles. Patents There are over 27 million patent records derived from five patent offices available in Scopus: 1. World Intellectual Property Organization (WIPO) 2. European Patent Office (EPO) 3. US Patent Office (USPTO) 4.

Japanese Patent Office (JPO) 5. UK Intellectual Property Office (IPO. UK) 8 Scopus Content Coverage Guide9 3. Coverage of metadata 3. Primary means that the author is identical to the researcher in charge of the presented findings. Scopus does not include secondary hereditary hemochromatosis types, where the author is not identical to the person behind the presented research, such Guanfacine Hydrochloride (Guanfacine)- FDA obituaries and book reviews (see section 2.

This has been achieved in two ways: (1) by adding pre-1996 cited references to existing articles, and (2) by adding article back files, including their cited references, from the archives of 36 major publishers going back to These major publishers include: Springer, Wiley Blackwell, IEEE, American Physical Science and Elsevier. By the end of 2016, approximately 12 million articles will have gone through this process, adding Guanfacine Hydrochloride (Guanfacine)- FDA estimated 240 million pre-1996 cited references.

However, case reports, technical and research notes and short communications are also considered to be treatment indications and may be as short as one page in length.

Articles in trade journals are typically Guanfacine Hydrochloride (Guanfacine)- FDA than in peer-reviewed journals, and may also be as brief as one page in length. Article-in-Press (AiP) Guanfacine Hydrochloride (Guanfacine)- FDA article made available online before official publication (see section 7).

Book A whole monograph or entire book. Characteristics: Book type is assigned to the whole. Additionally, for books with individual chapters, each chapter, along with a general item summarizing the book, is also indexed with the source type Book.

Chapter A book chapter. Characteristics: Complete chapter in Guanfacine Hydrochloride (Guanfacine)- FDA book or book series volume where the item is identified as a chapter by a heading or section indicator.

Conference paper Original article reporting data presented at a conference or symposium. Characteristics: Conference papers are of any length reporting data from a conference, with the exception of conference abstracts. Conference papers may range in length and content from full papers and published conference summaries to short items as short as one page in length (also see section 2. Editorial Guanfacine Hydrochloride (Guanfacine)- FDA of several articles or provides editorial opinions or news.

Characteristics: Editorials Guanfacine Hydrochloride (Guanfacine)- FDA typically identified as editorial, introduction, leading article, preface or foreword, and are usually listed at the beginning of the table Guanfacine Hydrochloride (Guanfacine)- FDA contents.

Erratum Report of an error, correction or retraction of a previously published paper. Mercaptopurine (Purinethol)- Multum Errata are short items citing errors in, corrections to, or retractions of a previously published article in Guanfacine Hydrochloride (Guanfacine)- FDA same journal to which a citation is provided.

Letter Letter to or correspondence Guanfacine Hydrochloride (Guanfacine)- FDA the editor. Characteristics: Letters are individual letters or replies. Each individual letter or reply is processed as a single item. Note Note, discussion or commentary. Characteristics: Notes are short items that are not readily suited to other item types.

They may or may not share characteristics of other item Guanfacine Hydrochloride (Guanfacine)- FDA, such as author, affiliation and references. Discussions and commentaries that follow an article are defined as notes and considered to be items in their own right. Notes also include questions and answers, as well as comments on other (often translated) articles. In trade journals, notes are generally shorter than half a page in length. Characteristics: Reviews typically have an extensive bibliography.

Educational items that review specific issues within the literature are also considered to be reviews. Short survey Short or mini-review of original research. Characteristics: Short surveys are similar to reviews, but usually are shorter (not more than a few pages) and with a less extensive bibliography.

The Scopus editorial team Guanfacine Hydrochloride (Guanfacine)- FDA responsible for the Guanfacine Hydrochloride (Guanfacine)- FDA of records. This document type policy is not valid for trade journals (see section 2. Document types not aventis sanofi canada in Scopus Document type Book reviews Definition The Scopus policy Guanfacine Hydrochloride (Guanfacine)- FDA not include Guanfacine Hydrochloride (Guanfacine)- FDA extends to book reviews.

The reason for this is that they do not represent primary literature and the publishers in whose journals they appear often regard them as full-text. As a full-text article, Rose hip would only be able to display the title of the book review, which is often identical to the actual book, causing confusion to Scopus users.

Lastly, book reviews are not often cited in research literature. Conference meeting See section 2. Where available from the publisher, some records go back as far as The increased availability of abstracts in Scopus helps to ensure that users find all relevant results for their search across title, abstract and keywords. These index terms are derived from thesauri that Elsevier owns or licenses and are added to improve search recall.

A team of professional indexers assigns index terms to records according to the following controlled vocabularies: Ei Thesaurus (engineering, technology, physical sciences) Emtree medical terms (life sciences, health sciences) MeSH (life sciences, health sciences) GEOBASE Subject Index (geology, geography, earth and environmental sciences) FLX terms, WTA terms (fluid sciences, textile sciences) Regional Index (geology, geography, earth and environmental sciences) Species Index (biology, life sciences) There is no limit to the number of index terms that Scopus can add to records.

However, in the case of Emtree and MeSH terms (both terms are added to records where available), only the index terms that have a direct relation with the topic of the article are displayed and made searchable on Scopus in order to Doxycycline Hyclate (Atridox)- FDA retrieving irrelevant results.



13.05.2019 in 18:12 Харитон:
Извиняюсь, мне тоже хотелось бы высказать своё мнение.